OlympusTSE:7733 +2.97%76 FCF Margin % is 7.80% as of Mar. 2026, which is 61% above its 10-year median of 4.85. GuruFocus rates TSE:7733 with a GF Score™ of 76/100 and a GF Value™ of 円2,593.47 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Olympus ranks better than 54.85% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Olympus's Free Cash Flow for the
three
months ended in Mar. 2026 was 円23,032 Mil. Olympus's Revenue for the
three
months ended in Mar. 2026 was 円295,281 Mil. Therefore, Olympus's FCF Margin % for the quarter that ended in Mar. 2026 was 7.80%.
The historical rank and industry rank for Olympus's FCF Margin % or its related term are showing as below:
TSE:7733'
s FCF Margin % Range Over the Past 10 Years
Min: -2.4 Med: 4.85 Max: 14.39
Current: 1.8
During the past 13 years, the highest FCF Margin % of Olympus was 14.39%. The lowest was -2.40%. And the median was 4.85%.
TSE:7733's FCF Margin % is ranked better than 54.85% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.03
vs TSE:7733: 1.80
Olympus FCF Margin % Related Terms
Olympus FCF Margin % Historical Data
* Premium members only.
The historical data trend for Olympus's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7733 vs ABT, SYK, MDT: FCF Margin % Comparison
For the Medical Devices subindustry, Olympus's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Olympus FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Olympus's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Olympus's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Olympus (TSE:7733) has a FCF Margin % of 7.80% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Olympus and its competitors. This is 61% above median its historical median of 4.85. According to the industry distribution chart, Olympus ranks #368 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 45.2%.
Is Olympus' FCF Margin % too high?
Olympus' current FCF Margin % of 7.80% is 61% above median its 10-year median of 4.85. Based on the distribution chart, Olympus ranks #368 out of 815 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Olympus has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Olympus' FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Olympus ranks #368 out of 815 companies for FCF Margin %. This puts Olympus in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Olympus and its competitors. Olympus's current FCF Margin % is 7.80%, which is 61% above median its own 10-year median of 4.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Olympus stock overvalued right now?
Based on GuruFocus' analysis, Olympus (TSE:7733) is currently considered Significantly Undervalued. The stock's GF Value™ is 円2,593.47, compared to a current price of 円1,684.00 — trading 35.1% below its estimated fair value. The current FCF Margin % is 7.80%, which is 61% above median its 10-year median of 4.85. Olympus' overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Olympus (TSE:7733), the current FCF Margin % is 7.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Olympus (TSE:7733) Overvalued in 2026?
Based on GuruFocus' analysis, Olympus stock appears to be undervalued.
The current stock price of 円1,684.00 is trading 35.1% below its estimated GF Value™ of 円2,593.47.
GuruFocus considers Olympus to be Significantly Undervalued.
Key valuation signals for TSE:7733:
FCF Margin %: 7.80% (61% above median its 10-year median of 4.85)
GF Value™: 円2,593.47 vs. price of 円1,684.00 (35.1% below fair value)
No single metric tells the full story. See the TSE:7733 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Olympus is a medical-device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2025, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.
76GF Score
Get the complete analysis for TSE:7733
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7733 has been successfully added to your 
